Galenica strengthens basic care with new pharmacy concept

21.10.25 07:55 Uhr

Werte in diesem Artikel
Aktien

90,00 CHF 0,60 CHF 0,67%

Galenica AG / Key word(s): Product Launch
Galenica strengthens basic care with new pharmacy concept

21.10.2025 / 07:55 CET/CEST

Wer­bung


Press release

  • Pharmacies play a key role in healthcare. 
  • Galenica is testing a new pharmacy concept with a focus on consultations and customer experience at the Amavita pharmacy in Zurich’s Glattzentrum. 
  • In doing so, Galenica is responding to changing customer needs and demonstrating what pharmacies might look like in the future.

Around 1,830 public pharmacies ensure nationwide basic care in Switzerland – more than 300,000 people visit a pharmacy every day. In addition to dispensing medicines, pharmacies increasingly offer services such as vaccinations, health checks and advice for acute complaints. Demographic change and the strained medical supply situation mean that demand for these local easily accessible services continues to grow.

Wer­bung

Galenica develops new pharmacy concept

To strengthen the role of pharmacies as a central point of contact for health issues, Galenica is working on new care models and the customer experience in pharmacies. A modernised Amavita pharmacy will open in Zurich’s Glattzentrum on 25 October 2025. It will serve as a pilot for a new pharmacy concept that more closely links consultation, store design and digital support. With the launch, Galenica is fundamentally redesigning the customer experience and showing what pharmacies can look like in the future.

 

The redesigned pharmacy offers express checkouts for quick shopping, fully private rooms for discreet consultations and new semi-private consultation areas. Here, specialists and customers can compare and discuss products and services together on screens. In doing so, Galenica is also responding to changing customer needs: Today, around 80% of customers first obtain information online before visiting a pharmacy. Galenica has been making targeted investments in connecting digital and in-store offerings for several years. The new pharmacy concept is a key component of this strategy.

 

“As Switzerland’s strongest healthcare network, we want to participate in shaping the role of pharmacies in health and care. To this end, we are investing specifically in modern space concepts, digitalisation, new offers and the further development of employees’ skills,” says Marc Werner, CEO of Galenica.

Wer­bung

Further pharmacies based on the new concept planned for 2026

With “Consultation plus,” pharmacies in the Galenica network already offer an easily accessible advisory service, for example for acute concerns such as bladder problems or skin problems as well as preventive health checks such as HerzCheck®. Depending on cantonal regulations, Amavita and Sun Store pharmacies also offer different vaccinations. With the “Cost containment package 2,” the federal government is also underlining the competencies of the pharmacy.
From 2027, pharmacy services such as vaccinations as well as measures for prevention and adherence to therapy will be covered by basic health insurance. The new pharmacy concept is helping to further expand consultations as a central task of the pharmacy.

 

The pharmacy in Glattzentrum is a pilot project that will be implemented with existing staff. Galenica gains insights into customer behaviour, processes and training needs, which are incorporated directly into the further development of the pharmacies. Additional pilot pharmacies are planned for 2026 – as the next step towards broader implementation at other locations.

 

Image material

A visualisation can be found here. Photos of the new Amavita pharmacy in Zurich’s Glattzentrum will be available on our website from 23 October 2025.

 

Visit for media representatives

Media representatives will have the opportunity to visit the new pharmacy from 9 a.m. to 11 a.m. on 23 October 2025. Please register with the Media Office.

 

Dates for the diary

23 October 2025 Galenica Group sales update
28 October 2025 Galenica Investor Day 2025

 

For further information, please contact:

Media Relations:
Iris Müller, Chief Communications Officer
Tel. +41 58 852 85 17
E-Mail: media@galenica.com
 

Welcome to the Galenica network!
Around 8,000 employees at Galenica work tirelessly to improve the health and well-being of the people of Switzerland every day. With its pharmacies, pharmaceutical logistics providers, products, services and home care, Galenica has a broad and successful position in the market. We are shaping the future of healthcare in collaboration with our strong partners – by drawing on the diverse skills and extensive expertise of our entire network. Our ambition is to fulfil the needs of customers and patients in the Swiss healthcare market seamlessly, efficiently and personally.

 

Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446). Find out more about Galenica at www.galenica.com.



End of Media Release
View original content: EQS News


Language: English
Company: Galenica AG
Untermattweg 8
3027 Bern
Switzerland
Phone: +41 058 852 81 11
E-mail: info@galenica.com
Internet: https://www.galenica.com
ISIN: CH0360674466
Listed: SIX Swiss Exchange
EQS News ID: 2215604

 
End of News EQS News Service

2215604  21.10.2025 CET/CEST

Ausgewählte Hebelprodukte auf Galenica

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Galenica

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Galenica AG

Wer­bung

Analysen zu Galenica AG

DatumRatingAnalyst
11.02.2013Galenica verkaufenVontobel Research
18.01.2013Galenica verkaufenVontobel Research
03.12.2012Galenica reduceVontobel Research
15.08.2012Galenica reduceVontobel Research
14.08.2012Galenica neutralSarasin Research
DatumRatingAnalyst
01.12.2010Galenica buyVontobel Research
17.09.2010Galenica buyVontobel Research
02.09.2010Galenica buyVontobel Research
27.08.2010Galenica buyVontobel Research
18.08.2010Galenica buyVontobel Research
DatumRatingAnalyst
14.08.2012Galenica neutralSarasin Research
10.07.2012Galenica neutralSarasin Research
09.07.2012Galenica holdVontobel Research
27.06.2012Galenica holdVontobel Research
13.03.2012Galenica neutralSarasin Research
DatumRatingAnalyst
11.02.2013Galenica verkaufenVontobel Research
18.01.2013Galenica verkaufenVontobel Research
03.12.2012Galenica reduceVontobel Research
15.08.2012Galenica reduceVontobel Research
26.07.2012Galenica reduceVontobel Research

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Galenica AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen